Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress

Diorio, D., Viau, V, & Meaney, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-09-03839.1993 · Cited by 1,151 · see citing works

The neurobiology and control of anxious states

Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 963 · see citing works

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · see citing works

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Izzo, A. A., Borrelli, F., Capasso, R., Marzo, V. D., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 851 · see citing works

Repeated Stress Induces Dendritic Spine Loss in the Rat Medial Prefrontal Cortex

Radley, J. J., Rocher, A. B., Miller, M., Janssen, W. G. M., Liston, C., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhi104 · Cited by 820 · see citing works

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771 · see citing works

Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear

Vidal-Gonzalez, I., Vidal-Gonzalez, B., Rauch, S. L., & Quirk, G. J. (2006) · Learning & Memory · doi:10.1101/lm.306106 · Cited by 705 · see citing works

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · see citing works

Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABA_A, and Glutamate Receptors

Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497 · see citing works

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475 · see citing works

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421 · see citing works

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410 · see citing works

Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · see citing works

Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT_1Areceptors

Zanelati, T., Biojone, C., Moreira, F., Guimarães, F., & Joca, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00521.x · Cited by 366 · see citing works

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364 · see citing works

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364 · see citing works

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

Campos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F. A., Guzmán, M., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001502 · Cited by 313 · see citing works

Role of the medial prefrontal cortex in coping and resilience

Maier, S. F., & Watkins, L. R. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.039 · Cited by 292 · see citing works

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

de Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.001 · Cited by 264 · see citing works

Behavioral control, the medial prefrontal cortex, and resilience

Maier, S. F., Amat, J., Baratta, M. V., Paul, E. D., & Watkins, L. R. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/smaier · Cited by 231 · see citing works

Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat.

Jinks, A., & McGregor, I. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00810-x · Cited by 229 · see citing works

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207 · see citing works

Hashish—IV

Mechoulam, R., & Gaoni, Y. (1965) · Tetrahedron · doi:10.1016/0040-4020(65)80064-3 · Cited by 197 · see citing works

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats

Resstel, L. B. M., Joca, S. R. L., Moreira, F. A., Corrêa, F. M. A., & Guimarães, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.016 · Cited by 182 · see citing works

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174 · see citing works

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

Campos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172 · see citing works

Specific Configuration of Dendritic Degeneration in Pyramidal Neurons of the Medial Prefrontal Cortex Induced by Differing Corticosteroid Regimens

Cerqueira, J., Taipa, R. J. F., Uylings, H. B. M., Almeida, O. F. X., & Sousa, N. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl108 · Cited by 171 · see citing works

Serotonergic regulation of neuronal excitability in the prefrontal cortex

Andrade, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.015 · Cited by 167 · see citing works

On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment

Stern, C. A. J., Gazarini, L., Takahashi, R. N., Guimarães, F. S., & Bertoglio, L. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.63 · Cited by 156 · see citing works

Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats

Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.09.045 · Cited by 146 · see citing works

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · see citing works

Glucocorticoid receptor-mediated inhibition by corticosterone of 5-ht1a autoreceptor functioning in the rat dorsal raphe nucleus

Laaris, N., Haj‐Dahmane, S., Hamon, M., & Lanfumey, L. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00095-n · Cited by 124 · see citing works

Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex

Casanovas, J. M., Hervás, I., & Artigas, F. (1999) · Neuroreport · doi:10.1097/00001756-199905140-00010 · Cited by 118 · see citing works

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112 · see citing works

Serotonergic activation reduces defensive freezing in the conditioned fear paradigm

Inoue, T. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02084-5 · Cited by 106 · see citing works

The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior

Fogaça, M. V., de Aguiar, D. C., Moreira, F. A., & Guimarães, F. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.007 · Cited by 89 · see citing works

Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress

Calvo, N., Martijena, I. D., Molina, V. A., & Volosin, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00515-0 · Cited by 80 · see citing works

Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience

Campos, A. C., Ferreira, F. R., Guimarães, F. S., & Lemos, J. I. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.062 · Cited by 75 · see citing works

Behavioral effects in the elevated plus maze of an NMDA antagonist injected into the dorsal hippocampus: influence of restraint stress

Padovan, C. M., Bel, E. A. D., & Guimarães, F. S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00361-0 · Cited by 72 · see citing works

The Formation and Stability of Recognition Memory: What Happens Upon Recall?

Davis, S., Renaudineau, S., Poirier, R., Poucet, B., Save, É., & Laroche, S. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00177 · Cited by 66 · see citing works

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Campos, A. C., de Paula Soares, V., Carvalho, M. C., Ferreira, F. R., Vicente, M. A., Brandão, M. L., Zuardi, A. W., Zangrossi, H., & Guimarães, F. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2878-7 · Cited by 65 · see citing works

Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test

Treit, D., Robinson, A., Rotzinger, S., & Pesold, C. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90045-r · Cited by 65 · see citing works

Different role of the ventral medial prefrontal cortex on modulation of innate and associative learned fear

Lisboa, S. F. D. S., Stecchini, M. F., Corrêa, F. M. D. A., Guimarães, F. S., & Resstel, L. B. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.048 · Cited by 62 · see citing works

Transient inactivation of the medial prefrontal cortex affects both anxiety and decision-making in male Wistar rats

de Visser, L. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00102 · Cited by 62 · see citing works

Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: Involvement of 5-HT7 receptors

García‐Iglesias, B. B., Mendoza‐Garrido, M. E., Gutiérrez‐Ospina, G., Rangel‐Barajas, C., Noyola-Díaz, M., & Terrón, J. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.013 · Cited by 47 · see citing works

Basal anxiety-like behavior predicts differences in dendritic morphology in the medial prefrontal cortex in two strains of rats

Miller, M. M., Morrison, J. H., & McEwen, B. S. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.029 · Cited by 46 · see citing works

5HT1A and 5HT1B receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats

Solati, J., Salari, A., & Bakhtiari, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.058 · Cited by 44 · see citing works

Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats

Fogaça, M. V., Gomes, F. V., Moreira, F. A., Guimarães, F. S., & de Aguiar, D. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2927-2 · Cited by 27 · see citing works

Cannabidiol as a Potential Treatment for Anxiety Disorders

Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 718 · see citing works

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 484 · see citing works

Cannabidiol, neuroprotection and neuropsychiatric disorders

Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446 · see citing works

Medial prefrontal cortex in neurological diseases

Xu, P., Chen, A., Li, Y., Xing, X., & Lü, H. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00006.2019 · Cited by 346 · see citing works

Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age

Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306 · see citing works

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors

Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, Á., Adell, A., & Díaz, Á. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.017 · Cited by 285 · see citing works

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294 · see citing works

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A., & Ranganathan, M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.209 · Cited by 236 · see citing works

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.001 · Cited by 208 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

Serotonin receptors in depression and anxiety: Insights from animal studies

Żmudzka, E., Sałaciak, K., Sapa, J., & Pytka, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.08.050 · Cited by 175 · see citing works

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 170 · see citing works

Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies

Suraev, A. S., Marshall, N. S., Vandrey, R. G., McCartney, D., Benson, M. J., McGregor, I. S., Grunstein, R. R., & Hoyos, C. M. (2020) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101339 · Cited by 162 · see citing works

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

González‐Cuevas, G., Martin‐Fardon, R., Kerr, T. M., Stouffer, D. G., Parsons, L. H., Hammell, D. C., Banks, S. L., Stinchcomb, A. L., & Weiss, F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0050-8 · Cited by 157 · see citing works

The Polypharmacological Effects of Cannabidiol

Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 163 · see citing works

Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders

Lee, J. L. C., Bertoglio, L. J., Guimarães, F. S., & Stevenson, C. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13724 · Cited by 140 · see citing works

Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings

Elsaid, S., Kloiber, S. M., & Foll, B. L. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.005 · Cited by 136 · see citing works

Cannabis Use and the Risk for Psychosis and Affective Disorders

Sideli, L., Quigley, H., Cascia, C. L., & Murray, R. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1674991 · Cited by 137 · see citing works

A review of methods for the chemical characterization of cannabis natural products

Leghissa, A., Hildenbrand, Z. L., & Schug, K. A. (2017) · Journal of Separation Science · doi:10.1002/jssc.201701003 · Cited by 131 · see citing works

Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP)

Klein, B. D., Jacobson, C. A., Metcalf, C. S., Smith, M. D., Wilcox, K. S., Hampson, A. J., & Kehne, J. H. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2287-8 · Cited by 125 · see citing works

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Melas, P. A., Scherma, M., Fratta, W., Cifani, C., & Fadda, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041863 · Cited by 124 · see citing works

Cannabinoid Regulation of Fear and Anxiety: an Update

Papagianni, E. P., & Stevenson, C. W. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1026-z · Cited by 100 · see citing works

Cannabidiol in the Treatment of Epilepsy

von Wrede, R. D., Helmstaedter, C., & Surges, R. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01003-y · Cited by 99 · see citing works

Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments

Renard, J., Norris, C., Rushlow, W. J., & Laviolette, S. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.006 · Cited by 97 · see citing works

Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms

Silote, G. P., Sartim, A. G., Sales, A. J., Eskelund, A., Guimarães, F. S., Wegener, G., & Joca, S. R. L. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.04.006 · Cited by 93 · see citing works

Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria

Campos, A. C., Brant, F., de Miranda, A. S., Machado, F. S., & Teixeira, A. L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.051 · Cited by 93 · see citing works

The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders

Marzo, V. D. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/vdimarzo · Cited by 91 · see citing works

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Štark, T., Kučerová, J., Iannotti, F. A., D’Addario, C., Marco, R. D., Pekařík, V., Dražanová, E., Piscitelli, F., Bari, M., Babinská, Z., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.035 · Cited by 89 · see citing works

Endocannabinoids, cannabinoids and the regulation of anxiety

Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 85 · see citing works

Cannabinoid therapy in epilepsy

Billakota, S., Devinsky, O., & Marsh, E. D. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000660 · Cited by 75 · see citing works

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders

Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.626010 · Cited by 78 · see citing works

Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System

Norris, C., Loureiro, M., Kramar, C. P., Zunder, J. S., Renard, J., Rushlow, W. J., & Laviolette, S. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.93 · Cited by 75 · see citing works

Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats

Rock, E. M., Limebeer, C. L., Petrie, G. N., Williams, L. A., Mechoulam, R., & Parker, L. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4626-5 · Cited by 74 · see citing works

Common neurocircuitry mediating drug and fear relapse in preclinical models

Goode, T. D., & Maren, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5024-3 · Cited by 71 · see citing works

Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 site

François, B. L., Soo, J., Millar, A., Daigle, M., Guisquet, A. L., Leman, S., Minier, F., Belzung, C., & Albert, P. R. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.07.002 · Cited by 70 · see citing works

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

Marinho, A. L. Z., Vila-Verde, C., Fogaça, M. V., & Guimarães, F. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.023 · Cited by 68 · see citing works

Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors

dos Santos, A. H., Lisboa, S. F. D. S., Sonego, A. B., Coutinho, D., Gomes, F. V., & Guimarães, F. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109637 · Cited by 67 · see citing works

Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects

Mendiguren, A., Aostri, E., & Pineda, J. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.029 · Cited by 66 · see citing works

Targeting the endocannabinoid system to treat anxiety-related disorders

Korem, N., Zer‐Aviv, T. M., Ganon-Elazar, E., Abush, H., & Akirav, I. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0058 · Cited by 64 · see citing works

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial

Martin, E. L., Strickland, J. C., Schlienz, N. J., Munson, J., Jackson, H., Bonn‐Miller, M. O., & Vandrey, R. G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.729800 · Cited by 62 · see citing works

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082323 · Cited by 66 · see citing works

Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors

Szkudlarek, H. J., Desai, S. J., Renard, J., Pereira, B. J. G., Norris, C., Jobson, C. E. L., Rajakumar, N., Allman, B. L., & Laviolette, S. R. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0282-7 · Cited by 62 · see citing works

Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders

Jurkus, R., Day, H. L. L., Guimarães, F. S., Lee, J. L. C., Bertoglio, L. J., & Stevenson, C. W. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00454 · Cited by 58 · see citing works

The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats

Shallcross, J., Hámor, P. U., Bechard, A. R., Romano, M., Knackstedt, L. A., & Schwendt, M. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00091 · Cited by 57 · see citing works

Cannabidiol Does Not Dampen Responses to Emotional Stimuli in Healthy Adults

Arndt, D. L., & de Wit, H. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0014 · Cited by 54 · see citing works

Medial prefrontal cortex serotonergic and GABAergic mechanisms modulate the expression of contextual fear: Intratelencephalic pathways and differential involvement of cortical subregions

Almada, R. C., Coimbra, N. C., & Brandão, M. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.001 · Cited by 49 · see citing works

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms

Soderstrom, K., Soliman, E., & Dross, R. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00720 · Cited by 51 · see citing works

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

Austrich-Olivares, A., García‐Gutiérrez, M. S., Illescas, L., Gasparyan, A., & Manzanares, J. (2022) · Pharmaceuticals · doi:10.3390/ph15040473 · Cited by 49 · see citing works

Evidences for the Anti-panic Actions of Cannabidiol

Soares-Rachetti, V. D. P., & Campos, A. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123955 · Cited by 47 · see citing works

Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action

Chaves, Y. C., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00667-3 · Cited by 48 · see citing works

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

Pintori, N., Caria, F., Luca, M. A. D., & Miliano, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065251 · Cited by 48 · see citing works

Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction

Song, C., Stevenson, C. W., Guimarães, F. S., & Lee, J. L. C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00493 · Cited by 46 · see citing works

Sexual dimorphic distribution of cannabinoid 1 receptor mRNA in adult C57BL/6J mice

Liu, X., Li, X., Zhao, G., Wang, F., & Wang, L. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24868 · Cited by 44 · see citing works

Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence

Lisboa, S. F. D. S., Borges, A. A., Nejo, P., Fassini, A., Guimarães, F. S., & Resstel, L. B. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.005 · Cited by 43 · see citing works

The role of cannabis in treating anxiety

Ameringen, M. V., Zhang, J., Patterson, B. A., & Turna, J. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000566 · Cited by 43 · see citing works

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders

Scarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 40 · see citing works

Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice

Assareh, N., Gururajan, A., Zhou, C., Luo, J. L., Kevin, R. C., & Arnold, J. C. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000565 · Cited by 40 · see citing works

A time‐dependent contribution of hippocampal CB1, CB2 and PPARγ receptors to cannabidiol‐induced disruption of fear memory consolidation

Raymundi, A. M., da Silva, T. R., Zampronio, A. R., Guimarães, F. S., Bertoglio, L. J., & Stern, C. A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14895 · Cited by 39 · see citing works

Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments

Mori, M., Meyer, E., da Silva, F. F., Milani, H., Guimarães, F. S., & de Oliveira, R. M. W. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15134 · Cited by 40 · see citing works

Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance

Narayan, A. J., Downey, L. A., Manning, B., & Hayley, A. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104941 · Cited by 36 · see citing works

Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes

Chaves, Y. C., Genaro, K., Stern, C. A. J., Guaita, G. D. O., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135020 · Cited by 35 · see citing works

Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits

Rossignoli, M. T., Lopes‐Aguiar, C., Ruggiero, R. N., da Silva, R. A. D. V., Bueno-Júnior, L. S., Kandratavicius, L., Peixoto-Santos, J. E., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.019 · Cited by 34 · see citing works

Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis

Yang, X., Bam, M., Nagarkatti, P. S., & Nagarkatti, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52362-8 · Cited by 32 · see citing works

Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review

Rodrigues, L. A., Caroba, M. E. S., Taba, F. K., Filev, R., & Gallassi, A. D. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172982 · Cited by 31 · see citing works

Endocannabinoid-serotonin systems interaction in health and disease

Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 30 · see citing works

Single and combined effects of plant‐derived and synthetic cannabinoids on cognition and cannabinoid‐associated withdrawal signs in mice

Myers, A. M., Siegele, P. B., Foss, J. D., Tuma, R. F., & Ward, S. J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14147 · Cited by 31 · see citing works

Serotonergic neuromodulation of synaptic plasticity

Higa, G. S. V., Viana, F. J. C., Francis-Oliveira, J., Cruvinel, E., Franchin, T. S., Marcourakis, T., Ulrich, H., & De Pasquale, R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110036 · Cited by 29 · see citing works

CBD and the 5-HT1A receptor: A medicinal and pharmacological review

Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28 · see citing works

Dissociation in control of physiological and behavioral responses to emotional stress by cholinergic neurotransmission in the bed nucleus of the stria terminalis in rats

Gouveia, M. K., Miguel, T. T., Busnardo, C., Scopinho, A. A., Corrêa, F. M. D. A., Nunes‐de‐Souza, R. L., & Crestani, C. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.018 · Cited by 28 · see citing works

Differential effects of CB1 receptor agonism in behavioural tests of unconditioned and conditioned fear in adult male rats

Simone, J. J., Green, M. R., Hodges, T. E., & McCormick, C. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.012 · Cited by 28 · see citing works

Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments

Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108913 · Cited by 27 · see citing works

Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors

Franzen, J. M., Werle, I., Vanz, F., de Oliveira, B. B., Nascimento, L. M. M., Guimarães, F. S., & Bertoglio, L. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109316 · Cited by 27 · see citing works

The Anxiolytic Effects of Cannabidiol (CBD)

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Campos, A. C., & Guimarães, F. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00097-1 · Cited by 27 · see citing works

Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory

Kaplan, J. S., Wagner, J. K., Reid, K., McGuinness, F., Arvila, S., Brooks, M., Stevenson, H., Jones, J., Risch, B., McGillis, T., et al. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.711639 · Cited by 26 · see citing works

New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine

Orsolini, L., Tomasetti, C., Valchera, A., Iasevoli, F., Buonaguro, E. F., Vellante, F., Fornaro, M., Fiengo, A. L. C., Mazza, M., Vecchiotti, R., et al. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1173545 · Cited by 25 · see citing works

Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor

Liu, Y., Li, J.-C., Gu, Y.-F., Qiu, R.-H., Huang, J., Xue, R., Li, S., Zhang, Y., Zhang, Y., & Zhang, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04102-2 · Cited by 24 · see citing works

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13997 · Cited by 25 · see citing works

Role and Function of Endocannabinoid System in Major Depressive Disease

Yarar, E. (2020) · Medical Cannabis and Cannabinoids · doi:10.1159/000511979 · Cited by 21 · see citing works

Autism and associated disorders: cannabis as a potential therapy

Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 21 · see citing works

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

de Bitencourt, R. M., Takahashi, R. N., & Carlini, E. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638032 · Cited by 21 · see citing works

Parasitic pharmacology: A plausible mechanism of action for cannabidiol

Groeneveld, G. J., & Martin, J. H. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14028 · Cited by 20 · see citing works

Exploring the impact of trauma type and extent of exposure on posttraumatic alterations in 5-HT1A expression

Lewis, M. W., Jones, R. T., & Davis, M. T. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00915-1 · Cited by 20 · see citing works

The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol

dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20 · see citing works

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

Umpierrez, L. S., Costa, P. A., Michelutti, E. A., Baracz, S. J., Sauer, M. K., Turner, A. J., Everett, N. A., Arnold, J. C., McGregor, I. S., & Cornish, J. L. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06119-3 · Cited by 20 · see citing works

CB1 and CB2 receptors in the bed nucleus of the stria terminalis differently modulate anxiety-like behaviors in rats

Gomes‐de‐Souza, L., Bianchi, P., Ferreira, W. C., Tomeo, R. A., Cruz, F. C., & Crestani, C. C. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110284 · Cited by 20 · see citing works

A Cup of Hemp Coffee by Moka Pot from Southern Italy: An UHPLC-HRMS Investigation

Piccolella, S., Crescente, G., Formato, M., & Pacifico, S. (2020) · Foods · doi:10.3390/foods9081123 · Cited by 18 · see citing works

Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds

Rybarczyk, A., Majchrzak‐Celińska, A., & Krajka‐Kuźniak, V. (2023) · Antioxidants · doi:10.3390/antiox12122052 · Cited by 18 · see citing works

Odorants: a tool to provide nonpharmacological intervention to reduce anxiety during normal and pathological aging

Ballanger, B., Bath, K. G., & Mandairon, N. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.007 · Cited by 17 · see citing works

Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction

Franzen, J. M., Vanz, F., Werle, I., Guimarães, F. S., & Bertoglio, L. J. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.08.002 · Cited by 16 · see citing works

Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents

Jenkins, B. W., Buckhalter, S., Perreault, M. L., & Khokhar, J. Y. (2021) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgab052 · Cited by 15 · see citing works

Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients

Zafar, R., Schlag, A. K., & Nutt, D. (2020) · Drug Science Policy and Law · doi:10.1177/2050324520974487 · Cited by 15 · see citing works

Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

Ghovanloo, M., Dib‐Hajj, S. D., Goodchild, S. J., Ruben, P. C., & Waxman, S. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1066455 · Cited by 14 · see citing works

Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer’s disease through CB1 activation and inflammation modulation

Toledano, R. S., & Akirav, I. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02213-0 · Cited by 13 · see citing works

Molecular Targets of Cannabinoids Associated with Depression

Paudel, P., Ross, S. A., & Li, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210623144658 · Cited by 14 · see citing works

Pharmacological and biochemical studies on the protective effects of melatonin during stress-induced behavioral and immunological changes in relation to oxidative stress in rats

Pal, R., Gulati, K., Banerjee, B. D., & Ray, A. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0240 · Cited by 13 · see citing works

Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies

Lisboa, S. F. D. S., Stern, C. A. J., Gazarini, L., & Bertoglio, L. J. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.03.007 · Cited by 12 · see citing works

Pharmacologie du cannabidiol : points de vigilance, conséquences et risques chez l’homme

Micallef, J., Batisse, A., & Revol, B. (2022) · Therapies · doi:10.1016/j.therap.2022.02.001 · Cited by 12 · see citing works

The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Ahmed, M., Boileau, I., Le Foll, B., Carvalho, A. F., & Kloiber, S. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-1926 · Cited by 11 · see citing works

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

Marinho, A. L. Z., Vila-Verde, C., Fogaça, M. V., & Guimarães, F. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.023 · Cited by 68 · see citing works

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174 · see citing works

Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: Additional evidence

Lisboa, S. F. D. S., Borges, A. A., Nejo, P., Fassini, A., Guimarães, F. S., & Resstel, L. B. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.005 · Cited by 43 · see citing works

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors

Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.033 · Cited by 156 · see citing works

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364 · see citing works